In patients with persistent post-COVID chemosensory disorders, complete recovery occurred in 61.5% with Cerebrolysin plus training, versus no recovery with training alone.
In plain wordsIn patients with post-COVID sensory disorders, complete recovery occurred in 61.5% with Cerebrolysin plus training, versus none with training alone.
- Peptide
- Cerebrolysin
- Outcome
- IncreaseComplete chemosensory recovery
- Study
n = 202
- Comparator
- Olfactory and gustatory trainings only
- Analysis
- Secondary
- Outcome group
- Neuroprotection · Nervous system and cognition
- Studied dose
- 5 ml/d, 5d/week · intramuscular · ≥ 8-24 weeksAs given in this study (human).
Measurements
- Complete recovery
- 61.5%
- Cerebrolysin
- Complete recovery
- 80 patients
- Cerebrolysin
Source sentences
Recovery was complete in 61.5% (n = 80) with cerebrolysin therapy and partial in 17% (n = 22). There was no recovery with trainings only.
2 context sentences(design, population, supporting numbers)
Patients were randomized into group 1 (n = 150): received cerebrolysin [5 ml/d (IM), 5d/week] and practiced olfactory and gustatory trainings, and group 2 (n = 100): practiced olfactory and gustatory trainings only, for ≥ 8-24 weeks.
Analyses for secondary outcome were done on 202 patients (group 1 = 130; group 2 = 72).